Peptidomimetics Therapeutics for Retinal Disease
Ocular disorders originating in the retina can result in a partial or total loss of vision, making drug delivery to the retina of vital importance. However, effectively delivering drugs to the retina remains a challenge for ophthalmologists due to various anatomical and physicochemical barriers in t...
Main Authors: | Dylan E. Parsons, Soo Hyeon Lee, Young Joo Sun, Gabriel Velez, Alexander G. Bassuk, Mark Smith, Vinit B. Mahajan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/3/339 |
Similar Items
-
Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm
by: Rajesh Kuppusamy, et al.
Published: (2023-03-01) -
Peptidomimetic-Based Asymmetric Catalysts
by: Ibrahim Khettar, et al.
Published: (2023-01-01) -
Peptidomimetic foldamers of β-secondary structural elements
by: Ross, J
Published: (2016) -
Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis
by: Ambra Guarnaccio, et al.
Published: (2012-03-01) -
Heterocycles as a Peptidomimetic Scaffold: Solid-Phase Synthesis Strategies
by: Aizhan Abdildinova, et al.
Published: (2021-05-01)